Genome Project Moves Up Deadline for 'Working Draft'

With private sector sequencing efforts nipping at its heels, the consortium directing the international Human Genome Project recently pushed up the deadline for completing a "working draft" of the human genetic blueprint from December 2001 to spring 2000. A "final draft" of the genome, with gaps closed and errors corrected, is scheduled for completion by 2003.1 The new deadline is based on a recent successfully completed three-year pilot phase of the project. Scientists will construct a worki

Written byEugene Russo
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

With private sector sequencing efforts nipping at its heels, the consortium directing the international Human Genome Project recently pushed up the deadline for completing a "working draft" of the human genetic blueprint from December 2001 to spring 2000. A "final draft" of the genome, with gaps closed and errors corrected, is scheduled for completion by 2003.1

The new deadline is based on a recent successfully completed three-year pilot phase of the project. Scientists will construct a working draft by first determining DNA sequences from mapped segments of DNA based on known locations in the genome. Data will then be assembled in overlapping stretches that reflect the accurate orientation of the DNA in the genome.

"When you look at the output of the pilot project effort," explains Francis Collins, director of the National Human Genome Research Institute (NHGRI), "It is clear that the economies of scale that one hoped would come ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery